Dason et al., 2023 - Google Patents
Guideline No. 437: diagnosis and management of adenomyosisDason et al., 2023
- Document ID
- 11531781001735476475
- Author
- Dason E
- Maxim M
- Sanders A
- Papillon-Smith J
- Ng D
- Chan C
- Sobel M
- Publication year
- Publication venue
- Journal of Obstetrics and Gynaecology Canada
External Links
Snippet
Objective To describe the current evidence-based diagnosis and management of adenomyosis. Target Population All patients with a uterus of reproductive age. Options Diagnostic options include transvaginal sonography and magnetic resonance imaging …
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/42—Gynaecological or obstetrical instruments or methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/02—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/08—Detecting organic movements or changes, e.g. tumours, cysts, swellings
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Marret et al. | Therapeutic management of uterine fibroid tumors: updated French guidelines | |
| Carranza-Mamane et al. | The management of uterine fibroids in women with otherwise unexplained infertility | |
| Vervoort et al. | The effect of laparoscopic resection of large niches in the uterine caesarean scar on symptoms, ultrasound findings and quality of life: a prospective cohort study | |
| Schepker et al. | Clinical diagnosis and therapy of uterine scar defects after caesarean section in non-pregnant women | |
| Van Voorhis | A 41-year-old woman with menorrhagia, anemia, and fibroids: review of treatment of uterine fibroids | |
| Li et al. | The investigation and management of adenomyosis in women who wish to improve or preserve fertility | |
| Singh et al. | Contemporary management of uterine fibroids: focus on emerging medical treatments | |
| Kroon et al. | Fibroids in infertility–consensus statement from ACCEPT (Australasian CREI Consensus Expert Panel on Trial evidence) | |
| Kodaman et al. | Intra-uterine adhesions and fertility outcome: how to optimize success? | |
| Dason et al. | Guideline No. 437: diagnosis and management of adenomyosis | |
| Roy et al. | Reproductive outcome following hysteroscopic myomectomy in patients with infertility and recurrent abortions | |
| Liu et al. | Vaginal delivery outcomes of pregnancies following ultrasound-guided high-intensity focused ultrasound ablation treatment for uterine fibroids | |
| Fulop et al. | NovaSure impedance controlled endometrial ablation: long-term follow-up results | |
| Mondal et al. | Accessory cavitated uterine malformation: Enhancing awareness about this unexplored perpetrator of dysmenorrhea | |
| Garavaglia et al. | Interstitial pregnancy after in vitro fertilization and embryo transfer following bilateral salpingectomy: report of two cases and literature review | |
| Lemmers et al. | MisoREST: Surgical versus expectant management in women with an incomplete evacuation of the uterus after misoprostol treatment for miscarriage: A cohort study | |
| Yang et al. | The usefulness of transvaginal hydrolaparoscopy in infertile women with abnormal hysterosalpingogram results but with no obvious pelvic pathology | |
| Fox | Management of heavy menstrual bleeding in general practice | |
| Sharma | An Ectopic pregnancy in the tubal interstitium: beware! | |
| Cirilli et al. | Emergency evaluation and management of vaginal bleeding in the nonpregnant patient | |
| Kahyaoglu et al. | Should diagnostic laparoscopy be performed initially or not, during infertility management of primary and secondary infertile women? A cross‐sectional study | |
| Aldape et al. | Global endometrial ablation in the presence of essure® microinserts | |
| Beebeejaun et al. | Heavy menstrual flow: current and future trends in management | |
| Seli | Infertility | |
| Yu et al. | Treatment of cornual pregnancy in a patient with adenomyosis by high-intensity focused ultrasound (HIFU) ablation: A case report |